Ken Cacciatore
Stock Analyst at TD Cowen
(0)
# 4930
Out of 5,293 analysts
17
Total ratings
27.27%
Success rate
-31.47%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeut... | Maintains: Outperform | 65 50 | 15 | 233.33% | 2 | Aug 9, 2023 | |
BHC Bausch Health Compan... | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jun 16, 2023 | |
TAK Takeda Pharmaceutica... | Maintains: Outperform | 30 20 | 14.9 | 34.23% | 4 | May 16, 2023 | |
ISEE IVERIC bio | Downgrades: Market Perform | n/a | n/a | n/a | 2 | May 8, 2023 | |
SCPH scPharmaceuticals | Initiates Coverage On: Outperform | 25 | 2.33 | 972.96% | 1 | Dec 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 35 | 14.11 | 148.05% | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 3.97 | 1159.45% | 1 | Jul 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 4.01 | 1146.88% | 1 | Oct 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | 22.62 | 98.94% | 1 | Apr 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 23 | 0.44 | 5127.27% | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 375 | 9.14 | 4002.84% | 1 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 22, 2017 |